These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Marfan syndrome: new clues to genotype-phenotype correlations. Ramirez F; Gayraud B; Pereira L Ann Med; 1999 Jun; 31(3):202-7. PubMed ID: 10442675 [TBL] [Abstract][Full Text] [Related]
3. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies. Hayward C; Brock DJ Hum Mutat; 1997; 10(6):415-23. PubMed ID: 9401003 [TBL] [Abstract][Full Text] [Related]
4. Microfibrils: a cornerstone of extracellular matrix and a key to understand Marfan syndrome. Bonetti MI Ital J Anat Embryol; 2009; 114(4):201-24. PubMed ID: 20578676 [TBL] [Abstract][Full Text] [Related]
5. Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management. Loeys BL; Matthys DM; de Paepe AM Acta Clin Belg; 2003; 58(1):3-11. PubMed ID: 12723256 [TBL] [Abstract][Full Text] [Related]
6. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels. Zeyer KA; Reinhardt DP Mutat Res Rev Mutat Res; 2015; 765():7-18. PubMed ID: 26281765 [TBL] [Abstract][Full Text] [Related]
7. The molecular genetics of Marfan syndrome and related microfibrillopathies. Robinson PN; Godfrey M J Med Genet; 2000 Jan; 37(1):9-25. PubMed ID: 10633129 [TBL] [Abstract][Full Text] [Related]
8. Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Dietz HC; Pyeritz RE Hum Mol Genet; 1995; 4 Spec No():1799-809. PubMed ID: 8541880 [TBL] [Abstract][Full Text] [Related]
9. The molecular basis of Marfan syndrome. Maslen CL; Glanville RW DNA Cell Biol; 1993 Sep; 12(7):561-72. PubMed ID: 8397814 [TBL] [Abstract][Full Text] [Related]
10. Marfan syndrome. Part 1: pathophysiology and diagnosis. CaƱadas V; Vilacosta I; Bruna I; Fuster V Nat Rev Cardiol; 2010 May; 7(5):256-65. PubMed ID: 20351703 [TBL] [Abstract][Full Text] [Related]
11. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights. Furthmayr H; Francke U Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339 [TBL] [Abstract][Full Text] [Related]
12. The fibrillin-Marfan syndrome connection. Ramirez F; Pereira L; Zhang H; Lee B Bioessays; 1993 Sep; 15(9):589-94. PubMed ID: 8240311 [TBL] [Abstract][Full Text] [Related]
13. Mutations of extracellular matrix components in vascular disease. Ramirez F; Pereira L Ann Thorac Surg; 1999 Jun; 67(6):1857-8; discussion 1868-70. PubMed ID: 10391325 [TBL] [Abstract][Full Text] [Related]
14. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. Ramirez F; Dietz HC J Cell Physiol; 2007 Nov; 213(2):326-30. PubMed ID: 17708531 [TBL] [Abstract][Full Text] [Related]
15. A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias. Jensen SA; Iqbal S; Bulsiewicz A; Handford PA Hum Mol Genet; 2015 Aug; 24(15):4454-63. PubMed ID: 25979247 [TBL] [Abstract][Full Text] [Related]
16. Identification of defects in the fibrillin gene and protein in individuals with the Marfan syndrome and related disorders. Milewicz DM Tex Heart Inst J; 1994; 21(1):22-9. PubMed ID: 8180508 [TBL] [Abstract][Full Text] [Related]